David Padua

David Padua

Auto-generated profile, based on publicly available information

David Padua

Cancer Biology and Genetics Program

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2008 in Nature
Verified
Journal Article
Closed access
PDF file
STSohail F. Tavazoie
Sohail F. Tavazoie
CAClaudio Alarcón
Claudio Alarcón
TOThordur Oskarsson
Thordur Oskarsson
DPDavid Padua
David Padua
QWQiongqing Wang
Qiongqing Wang
JMJoan Massagué
Joan Massagué

1 April 2008 in Cell
Verified
Journal Article
Closed access
DPDavid Padua
David Padua
XZXiang H.-F. Zhang
Xiang H.-F. Zhang
QWQiongqing Wang
Qiongqing Wang
CNCristina Nadal
Cristina Nadal
WGWilliam L. Gerald
William L. Gerald
JMJoan Massagué
Joan Massagué

2 December 2008 in Cell Research
Verified
Journal Article
Closed access
DPDavid Padua
David Padua
JMJoan Massagué
Joan Massagué

17 April 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
AMAndy J. Minn
Andy J. Minn
GGGaorav P. Gupta
Gaorav P. Gupta
DPDavid Padua
David Padua
PBPaula Bos
Paula Bos
DNDon X. Nguyen
Don X. Nguyen
JMJoan Massagué
Joan Massagué
The association between large tumor size and metastatic risk in a majority of clinical cancers has led to questions as to whether these observations are causally related or whether one is simply a marker for the other. This is partly due to an uncertainty about how metastasis-promoting gene expression changes can arise in primary tumors. We investigated this question through the analysis of a previously defined “lung metastasis gene-expression signature” (LMS) that mediates experimental breast cancer metastasis selectively to the lung and is expressed by primary human breast cancer with a high risk for developing lung metastasis. Experimentally, we demonstrate that the LMS promotes primary tumor growth that enriches for LMS + cells, and it allows for intravasation after reaching a critical tumor size. Clinically, this corresponds to LMS + tumors being larger at diagnosis compared with LMS − tumors and to a marked rise in the incidence of metastasis after LMS + tumors reach 2 cm. Patients with LMS-expressing primary tumors selectively fail in the lung compared with the bone or other visceral sites and have a worse overall survival. The mechanistic linkage between metastasis gene expression, accelerated tumor growth, and likelihood of metastatic recurrence provided by the LMS may help to explain observations of prognostic gene signatures in primary cancer and how tumor growth can both lead to metastasis and be a marker for cells destined to metastasize.

22 August 2014 in BioEssays
Verified
Journal Article
Closed access
PDF file
EMEmeran Mayer
Emeran Mayer
DPDavid Padua
David Padua
KTKirsten Tillisch
Kirsten Tillisch

1 December 2013 in Cell Reports
Verified
Journal Article
Open access
MSMarko Stankic
Marko Stankic
SPSvetlana Pavlovic
Svetlana Pavlovic
YCYvette Chin
Yvette Chin
EBEdi Brogi
Edi Brogi
DPDavid Padua
David Padua
RBRobert Benezra
Robert Benezra
ID genes are required for breast cancer colonization of the lungs, but the mechanism remains poorly understood. Here, we show that Id1 expression induces a stem-like phenotype in breast cancer cells while retaining epithelial properties, contrary to the notion that cancer stem-like properties are inextricably linked to the mesenchymal state. During metastatic colonization, Id1 induces a mesenchymal-to-epithelial transition (MET), specifically in cells whose mesenchymal state is dependent on the Id1 target protein Twist1, but not at the primary site, where this state is controlled by the zinc finger protein Snail1. Knockdown of Id expression in metastasizing cells prevents MET and dramatically reduces lung colonization. Furthermore, Id1 is induced by transforming growth factor (TGF)-β only in cells that have first undergone epithelial-to-mesenchymal transition (EMT), demonstrating that EMT is a prerequisite for subsequent Id1-induced MET during lung colonization. Collectively, these studies underscore the importance of Id-mediated phenotypic switching during distinct stages of breast cancer metastasis.